Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same

Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same

US Patent 6814962 · Granted Nov 9, 2004

Estimated economic value: $223,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Low dose pridopidine for Parkinson's Disease and other diseases associated with 2025
Use of pridopidine for treating rett syndrome2024
Pridopidine for treating drug induced dyskinesias2024
Use of pridopidine for treating dystonias2023
Use of pridopidine to improve cognitive function and for treating Alzheimer's di2022
Method of treating amyotrophic lateral sclerosis with pridopidine2022
Use of pridopidine for the treatment of fragile X syndrome2022
Use of pridopidine for treating functional decline2021
Pridopidine for treating drug induced dyskinesias2021
Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis 2020
Allele-specific therapy for Huntington disease haplotypes2020
Use of pridopidine to improve cognitive function and for treating Alzheimer's di2020